414 related articles for article (PubMed ID: 30323594)
1. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
[TBL] [Abstract][Full Text] [Related]
2. Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes.
Tan S; Tao Z; Loo S; Su L; Chen X; Ye L
Sci Rep; 2019 Oct; 9(1):14404. PubMed ID: 31591436
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
[TBL] [Abstract][Full Text] [Related]
4. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
5. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.
Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S
Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209
[TBL] [Abstract][Full Text] [Related]
6. Assessment of mitophagy in human iPSC-derived cardiomyocytes.
Yang M; Fu JD; Zou J; Sridharan D; Zhao MT; Singh H; Krigman J; Khan M; Xin G; Sun N
Autophagy; 2022 Oct; 18(10):2481-2494. PubMed ID: 35220905
[TBL] [Abstract][Full Text] [Related]
7. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
[TBL] [Abstract][Full Text] [Related]
8. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
[TBL] [Abstract][Full Text] [Related]
9. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
10. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.
Ito E; Miyagawa S; Takeda M; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Mochizuki-Oda N; Yasuda S; Sato Y; Sawa Y
Sci Rep; 2019 Feb; 9(1):1881. PubMed ID: 30760836
[TBL] [Abstract][Full Text] [Related]
12. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
[TBL] [Abstract][Full Text] [Related]
13. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
14. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y
Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124
[TBL] [Abstract][Full Text] [Related]
15. Disruption of histamine/H
Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
[TBL] [Abstract][Full Text] [Related]
16. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.
Gao Y; Su L; Wei Y; Tan S; Hu Z; Tao Z; Kovalik JP; Soong TW; Zhang J; Pu J; Ye L
Theranostics; 2023; 13(11):3872-3896. PubMed ID: 37441603
[No Abstract] [Full Text] [Related]
18. Gene-Edited Human-Induced Pluripotent Stem Cell Lines to Elucidate
Inácio JM; Nunes MM; Almeida M; Cristo F; Anjos R; Belo JA
Cells; 2023 Feb; 12(4):. PubMed ID: 36831187
[TBL] [Abstract][Full Text] [Related]
19. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.
Uosaki H; Fukushima H; Takeuchi A; Matsuoka S; Nakatsuji N; Yamanaka S; Yamashita JK
PLoS One; 2011; 6(8):e23657. PubMed ID: 21876760
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
Tao Z; Loo S; Su L; Tan S; Tee G; Gan SU; Zhang J; Chen X; Ye L
Cardiovasc Res; 2021 May; 117(6):1578-1591. PubMed ID: 32666104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
